| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 7e-12 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.081 | 0.08 |